Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. There are two types of pneumococcal vaccines: conjugate vaccines and polysaccharide vaccines.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Pneumococcal Vaccines industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
PPSV 23
PCV 7/13
PCV 10
Market Segment by Product Application
For Infants
For Children (2-10)
For Person (10-64)
For The Old (?65)
Finally, the report provides detailed profile and data information analysis of leading company.
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Pneumococcal Vaccines consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Pneumococcal Vaccines market by identifying its various subsegments.
3.Focuses on the key global Pneumococcal Vaccines manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Pneumococcal Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Pneumococcal Vaccines submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Pneumococcal Vaccines Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Pneumococcal Vaccines Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Pneumococcal Vaccines Segment by Type
2.1.1 PPSV 23
2.1.2 PCV 7/13
2.1.3 PCV 10
2.2 Market Analysis by Application
2.2.1 For Infants
2.2.2 For Children (2-10)
2.2.3 For Person (10-64)
2.2.4 For The Old (?65)
2.3 Global Pneumococcal Vaccines Market Comparison by Regions (2017-2027)
2.3.1 Global Pneumococcal Vaccines Market Size (2017-2027)
2.3.2 North America Pneumococcal Vaccines Status and Prospect (2017-2027)
2.3.3 Europe Pneumococcal Vaccines Status and Prospect (2017-2027)
2.3.4 China Pneumococcal Vaccines Status and Prospect (2017-2027)
2.3.5 Japan Pneumococcal Vaccines Status and Prospect (2017-2027)
2.3.6 Southeast Asia Pneumococcal Vaccines Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Pneumococcal Vaccines Industry Impact
2.5.1 Pneumococcal Vaccines Business Impact Assessment - Covid-19
2.5.2 Market Trends and Pneumococcal Vaccines Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Pneumococcal Vaccines Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Pneumococcal Vaccines Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Pneumococcal Vaccines Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Pneumococcal Vaccines Manufacturer Market Share
3.5 Top 10 Pneumococcal Vaccines Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Pneumococcal Vaccines Market
3.7 Key Manufacturers Pneumococcal Vaccines Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Pneumococcal Vaccines Industry Key Manufacturers
4.1 Pfizer
4.1.1 Compan Detail
4.1.2 Pfizer Pneumococcal Vaccines Product Introduction, Application and Specification
4.1.3 Pfizer 178 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Pfizer News
4.2 Sanofi
4.2.1 Compan Detail
4.2.2 Sanofi Pneumococcal Vaccines Product Introduction, Application and Specification
4.2.3 Sanofi Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Pfizer News
4.3 GSK
4.3.1 Compan Detail
4.3.2 GSK Pneumococcal Vaccines Product Introduction, Application and Specification
4.3.3 GSK Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 GSK News
4.4 Merck
4.4.1 Compan Detail
4.4.2 Merck Pneumococcal Vaccines Product Introduction, Application and Specification
4.4.3 Merck Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Merck News
4.5 Eli Lilly
4.5.1 Compan Detail
4.5.2 Merck Pneumococcal Vaccines Product Introduction, Application and Specification
4.5.3 Eli Lilly Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Eli Lilly News
4.6 AstraZeneca
4.6.1 Compan Detail
4.6.2 AstraZeneca Pneumococcal Vaccines Product Introduction, Application and Specification
4.6.3 AstraZeneca Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 AstraZeneca News
4.7 Abera
4.7.1 Compan Detail
4.7.2 Abera Pneumococcal Vaccines Product Introduction, Application and Specification
4.7.3 Abera Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 S K Chemicals
4.8.1 Compan Detail
4.8.2 S K Chemicals Pneumococcal Vaccines Product Introduction, Application and Specification
4.8.3 S K Chemicals Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 S K Chemicals News
4.9 Beijing Minhai Biotechnology
4.9.1 Compan Detail
4.9.2 Beijing Minhai Biotechnology Pneumococcal Vaccines Product Introduction, Application and Specification
4.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Beijing Minhai Biotechnology News
4.10 Baxter
4.10.1 Compan Detail
4.10.2 Baxter Pneumococcal Vaccines Product Introduction, Application and Specification
4.10.3 Baxter Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Baxter News
4.11 Biken
4.11.1 Compan Detail
4.11.2 Biken Pneumococcal Vaccines Product Introduction, Application and Specification
4.11.3 Biken Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Biken News
4.12 Celgene Corporation
4.12.1 Compan Detail
4.12.2 Celgene Corporation Pneumococcal Vaccines Product Introduction, Application and Specification
4.12.3 Celgene Corporation Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Celgene Corporation News
4.13 Panacea Biotec
4.13.1 Company Details
4.13.2 Panacea Biotec Pneumococcal Vaccines Product Introduction, Application and Specification
4.13.3 Panacea Biotec Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Panacea Biotec News
4.14 Serum Institute of India
4.14.1 Compan Detail
4.14.2 Serum Institute of India Pneumococcal Vaccines Product Introduction, Application and Specification
4.14.3 Serum Institute of India Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Serum Institute of India News
4.15 Genentech
4.15.1 Compan Detail
4.15.2 Genentech Pneumococcal Vaccines Product Introduction, Application and Specification
4.15.3 Genentech Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Genentech News
4.16 Genocea Biosciences
4.16.1 Compan Detail
4.16.2 Genocea Biosciences Pneumococcal Vaccines Product Introduction, Application and Specification
4.16.3 Genocea Biosciences Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Genocea Biosciences News
4.17 ImmunoBiology
4.17.1 Compan Detail
4.17.2 ImmunoBiology Pneumococcal Vaccines Product Introduction, Application and Specification
4.17.3 ImmunoBiology Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 ImmunoBiology News
4.18 Lupin
4.18.1 Compan Detail
4.18.2 Lupin Pneumococcal Vaccines Product Introduction, Application and Specification
4.18.3 Lupin Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 Lupin News
4.19 Nuron Biotech
4.19.1 Compan Detail
4.19.2 Nuron Biotech Pneumococcal Vaccines Product Introduction, Application and Specification
4.19.3 Nuron Biotech Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 Nuron Biotech News
4.20 Biogen
4.20.1 Compan Detail
4.20.2 Biogen Pneumococcal Vaccines Product Introduction, Application and Specification
4.20.3 Biogen Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.20.4 Main Business Overview
4.20.5 Biogen News
4.21 Valneva Austria
4.21.1 Compan Detail
4.21.2 Valneva Austria Pneumococcal Vaccines Product Introduction, Application and Specification
4.21.3 Valneva Austria Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.21.4 Main Business Overview
4.21.5 Valneva Austria News
4.22 Sinovac
4.22.1 Compan Detail
4.22.2 Sinovac Pneumococcal Vaccines Product Introduction, Application and Specification
4.22.3 Sinovac Pneumococcal Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.22.4 Main Business Overview
4.22.5 Sinovac News
5 Global Pneumococcal Vaccines Market Segment by Big Type
5.1 Global Pneumococcal Vaccines Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Pneumococcal Vaccines Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Pneumococcal Vaccines Revenue and Market Share by Big Type (2017-2022)
5.2 PPSV 23 Sales Growth Rate and Price
5.2.1 Global PPSV 23 Sales Growth Rate (2017-2022)
5.2.2 Global PPSV 23 Price (2017-2022)
5.3 PCV 7/13 Sales Growth Rate and Price
5.3.1 Global PCV 7/13 Sales Growth Rate (2017-2022)
5.3.2 Global PCV 7/13 Price (2017-2022)
5.4 PCV 10 Sales Growth Rate and Price
5.4.1 Global PCV 10 Sales Growth Rate (2017-2022)
5.4.2 Global PCV 10 Price (2017-2022)
6 Global Pneumococcal Vaccines Market Segment by Big Application
6.1 Global Pneumococcal Vaccines Sales Market Share by Big Application (2017-2022)
6.2 For Infants Sales Growth Rate (2017-2022)
6.3 For Children (2-10) Sales Growth Rate (2017-2022)
6.4 For Person (10-64) Sales Growth Rate (2017-2022)
6.5 For The Old (?65) Sales Growth Rate (2017-2022)
7 Global Pneumococcal Vaccines Forecast
7.1 Global Pneumococcal Vaccines Revenue, Sales and Growth Rate (2022-2027)
7.2 Pneumococcal Vaccines Market Forecast by Regions (2022-2027)
7.2.1 North America Pneumococcal Vaccines Market Forecast (2022-2027)
7.2.2 Europe Pneumococcal Vaccines Market Forecast (2022-2027)
7.2.3 China Pneumococcal Vaccines Market Forecast (2022-2027)
7.2.4 Japan Pneumococcal Vaccines Market Forecast (2022-2027)
7.2.5 Southeast Asia Pneumococcal Vaccines Market Forecast (2022-2027)
7.2.6 Other Regions Pneumococcal Vaccines Market Forecast (2022-2027)
7.3 Pneumococcal Vaccines Market Forecast by Type (2022-2027)
7.3.1 Global Pneumococcal Vaccines Sales Forecast by Type (2022-2027)
7.3.2 Global Pneumococcal Vaccines Market Share Forecast by Type (2022-2027)
7.4 Pneumococcal Vaccines Market Forecast by Application (2022-2027)
7.4.1 Global Pneumococcal Vaccines Sales Forecast by Application (2022-2027)
7.4.2 Global Pneumococcal Vaccines Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Pneumococcal Vaccines Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Pneumococcal Vaccines Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Pneumococcal Vaccines
Figure Market Concentration Ratio and Market Maturity Analysis of Pneumococcal Vaccines
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Pneumococcal Vaccines Market Size by Big Type
Figure Global Market Share of Pneumococcal Vaccines by Big Type in 2021
Figure PPSV 23 Picture (2017-2022)
Figure PCV 7/13 Picture (2017-2022)
Global Pneumococcal Vaccines Market Size by Big Application
Table Global Pneumococcal Vaccines Market Size by Application
Figure Global Pneumococcal Vaccines Market Share by Big Application in 2021
Figure For Infants Picture
Figure For Children (2-10) Picture
Figure For Person (10-64) Picture
Figure For The Old (?65) Picture
Table Global Pneumococcal Vaccines Comparison by Regions (M USD) (2017-2027)
Figure Global Pneumococcal Vaccines Market Size (Million US$) (2017-2027)
Figure North America Pneumococcal Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Pneumococcal Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Figure China Pneumococcal Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Pneumococcal Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Pneumococcal Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Pneumococcal Vaccines Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Pneumococcal Vaccines Sales by Manufacturer (2017-2022)
Figure Global Pneumococcal Vaccines Sales Market Share by Manufacturer in 2021
Table Global Pneumococcal Vaccines Revenue by Manufacturer (2017-2022)
Figure Global Pneumococcal Vaccines Revenue Market Share by Manufacturer in 2021
Table Global Pneumococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Pneumococcal Vaccines Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Pneumococcal Vaccines Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Pneumococcal Vaccines Market
Table Key Manufacturers Pneumococcal Vaccines Product Type
Table Mergers & Acquisitions Planning
Table Pfizer Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Pfizer
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Sanofi Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Sanofi
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi Recent Development
Table GSK Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of GSK
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GSK Main Business
Table GSK Recent Development
Table Merck Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Merck
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Merck Main Business
Table Merck Recent Development
Table Eli Lilly Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Eli Lilly
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table AstraZeneca Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of AstraZeneca
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Abera Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Abera
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Abera Main Business
Table Abera Recent Development
Table S K Chemicals Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of S K Chemicals
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table S K Chemicals Main Business
Table S K Chemicals Recent Development
Table Beijing Minhai Biotechnology Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Beijing Minhai Biotechnology
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Beijing Minhai Biotechnology Main Business
Table Beijing Minhai Biotechnology Recent Development
Table Baxter Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Baxter
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Baxter Main Business
Table Baxter Recent Development
Table Biken Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Biken
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biken Main Business
Table Biken Recent Development
Table Celgene Corporation Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Celgene Corporation
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Celgene Corporation Main Business
Table Celgene Corporation Recent Development
Table Panacea Biotec Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Panacea Biotec
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Panacea Biotec Main Business
Table Panacea Biotec Recent Development
Table Serum Institute of India Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Serum Institute of India
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Serum Institute of India Main Business
Table Serum Institute of India Recent Development
Table Genocea Biosciences Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Genocea Biosciences
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Genocea Biosciences Main Business
Table Genocea Biosciences Recent Development
Table ImmunoBiology Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of ImmunoBiology
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table ImmunoBiology Main Business
Table ImmunoBiology Recent Development
Table Lupin Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Lupin
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Lupin Main Business
Table Lupin Recent Development
Table Nuron Biotech Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Nuron Biotech
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Nuron Biotech Main Business
Table Nuron Biotech Recent Development
Table Biogen Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Biogen
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biogen Main Business
Table Biogen Recent Development
Table Valneva Austria Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Valneva Austria
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Valneva Austria Main Business
Table Valneva Austria Recent Development
Table Sinovac Company Profile
Table Pneumococcal Vaccines Product Introduction, Application and Specification of Sinovac
Table Pneumococcal Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sinovac Main Business
Table Sinovac Recent Development
Figure Global Pneumococcal Vaccines Sales and Growth Rate (2017-2022)
Figure Global Pneumococcal Vaccines Revenue and Growth Rate (2017-2022)
Table Global Pneumococcal Vaccines Sales by Regions (2017-2022)
Figure Global Pneumococcal Vaccines Sales Market Share by Regions in 2021
Table Global Pneumococcal Vaccines Revenue by Regions (2017-2022)
Figure Global Pneumococcal Vaccines Revenue Market Share by Regions in 2021
Figure North America Pneumococcal Vaccines Sales and Growth Rate (2017-2022)
Figure Europe Pneumococcal Vaccines Sales and Growth Rate (2017-2022)
Figure China Pneumococcal Vaccines Sales and Growth Rate (2017-2022)
Figure Japan Pneumococcal Vaccines Sales and Growth Rate (2017-2022)
Figure Southeast Asia Pneumococcal Vaccines Sales and Growth Rate (2017-2022)
Figure Other Regions Pneumococcal Vaccines Sales and Growth Rate (2017-2022)
Table Global Pneumococcal Vaccines Sales by Big Type (2017-2022)
Table Global Pneumococcal Vaccines Sales Market Share by Big Type (2017-2022)
Figure Global Pneumococcal Vaccines Sales Market Share by Big Type in 2019
Table Global Pneumococcal Vaccines Revenue by Big Type (2017-2022)
Table Global Pneumococcal Vaccines Revenue Market Share by Big Type (2017-2022)
Table Global Pneumococcal Vaccines Revenue Market Share by Big Type in 2019
Figure Global PPSV 23 Sales Growth Rate (2017-2022)
Figure Global PPSV 23 Price (2017-2022)
Figure Global PCV 7/13 Sales Growth Rate (2017-2022)
Figure Global PCV 7/13 Price (2017-2022)
Figure Global PCV 10 Sales Growth Rate (2017-2022)
Table Global Pneumococcal Vaccines Sales by Big Application (2017-2022)
Table Global Pneumococcal Vaccines Sales Market Share by Big Application (2017-2022)
Figure Global Pneumococcal Vaccines Sales Market Share by Big Application in 2019
Figure Global For Infants Sales Growth Rate (2017-2022)
Figure Global For Children (2-10) Sales Growth Rate (2017-2022)
Figure Global For Person (10-64) Sales Growth Rate (2017-2022)
Figure Global For The Old (?65) Sales Growth Rate (2017-2022)
Figure Global Pneumococcal Vaccines Sales and Growth Rate (2022-2027)
Figure Global Pneumococcal Vaccines Revenue and Growth Rate (2022-2027)
Table Global Pneumococcal Vaccines Sales Forecast by Regions (2022-2027)
Table Global Pneumococcal Vaccines Market Share Forecast by Regions (2022-2027)
Figure North America Sales Pneumococcal Vaccines Market Forecast (2022-2027)
Figure Europe Sales Pneumococcal Vaccines Market Forecast (2022-2027)
Figure China Sales Pneumococcal Vaccines Market Forecast (2022-2027)
Figure Japan Sales Pneumococcal Vaccines Market Forecast (2022-2027)
Figure Southeast Asia Sales Pneumococcal Vaccines Market Forecast (2022-2027)
Figure Other Regions Sales Pneumococcal Vaccines Market Forecast (2022-2027)
Table Global Pneumococcal Vaccines Sales Forecast by Type (2022-2027)
Table Global Pneumococcal Vaccines Market Share Forecast by Type (2022-2027)
Table Global Pneumococcal Vaccines Sales Forecast by Application (2022-2027)
Table Global Pneumococcal Vaccines Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pneumococcal Vaccines
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Pneumococcal Vaccines Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Pneumococcal Vaccines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Pneumococcal Vaccines Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Pneumococcal Vaccines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Pneumococcal Vaccines Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Pneumococcal Vaccines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Pneumococcal Vaccines Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Pneumococcal Vaccines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)